The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Preclinical and Clinical Studies of MMP Inhibitors in Cancer
Abstract
ABSTRACT: The role of matrix metalloproteinases in tumor angiogenesis and growth is now well recognized for models of both human and animal cancer. Clinical studies currently under way with the prototype matrix metalloproteinase inhibitor, marimastat, will establish whether inhibitors of these enzymes are of benefit in the treatment of different types of human cancer. On chronic therapy in humans, marimastat induces a reversible tendinitis that can also be detected in certain animal species. This paper compares the ability of broad‐spectrum and various types of selective matrix metalloproteinase inhibitors to induce tendinitis and to exhibit anticancer effects in an animal cancer model. Under conditions in which both systemic exposure and inhibitor potency are controlled, selective inhibitors are less pro‐tendinitic, but are weaker anticancer agents than broad‐spectrum agents such as marimastat. The clinical relevance of these findings is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Cited by
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
KJÆR, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00031.2003 · Cited by 1,586
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Self-citationIs there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 832
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Metadata
- Authors
- DRUMMOND, A. H., BECKETT, P., BROWN, P. D., BONE, E. A., DAVIDSON, A. H., GALLOWAY, W. A., GEARING, A. J. H., HUXLEY, P., LABER, D., MCCOURT, M., WHITTAKER, M., WOOD, L. M., & WRIGHT, A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 878
- Issue
- 1
- Pages
- 228-235
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2154390735
- Cited by
- 219
- References
- 1
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical and Clinical Studies of MMP Inhibitors in Cancer. https://app.cochat.ai/papers/10.1111/j.1749-6632.1999.tb07688.x
- The paper
- DRUMMOND, A. H., BECKETT, P., BROWN, P. D., BONE, E. A., DAVIDSON, A. H., GALLOWAY, W. A., GEARING, A. J. H., HUXLEY, P., LABER, D., MCCOURT, M., WHITTAKER, M., WOOD, L. M., & WRIGHT, A. (1999). Preclinical and Clinical Studies of MMP Inhibitors in Cancer. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb07688.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.